T1	Participants 71 94	essential hypertension.
T2	Participants 248 437	19 ambulatory men with moderated essential hypertension (supine diastolic blood pressure [DPB], 100 to 120 mm Hg after receiving placebo for two weeks) whose sodium intake was unrestricted.
T3	Participants 438 511	The captopril group included 12 patients and the propranolol group seven.
T4	Participants 1143 1175	moderate essential hypertension.
